Steve Schonfeld’s Pulse Biosciences PLSE Stock Holding History

Steve Schonfeld’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26,300	Closed	-$40K	–	3120
2022 Q2	$40K	Buy	+26,300	New	+$66.1K	﹤0.01%	2248

Other funds holding PLSE

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's PLSE Position: Q3 2022 in Review

Steve Schonfeld sold out of Pulse Biosciences (PLSE) in Q3 2022, closing a stake of 26,300 shares — an estimated $40K sold.

Steve Schonfeld first reported a position in PLSE in Q2 2022 and held it in 1 quarter. The position peaked at $40K in Q2 2022. 31 funds tracked by Wall St. Rank hold PLSE as of Q3 2022.

Steve Schonfeld reported no remaining Pulse Biosciences position as of Q3 2022 after selling out during the quarter.
Steve Schonfeld sold 26,300 Pulse Biosciences shares in Q3 2022, an estimated $40K.
Steve Schonfeld first reported a position in Pulse Biosciences in Q2 2022 and held it in 1 quarter.
Steve Schonfeld's Pulse Biosciences position peaked at $40K in Q2 2022.
31 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.